A bridge, but to where?

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 6, 2003, Pages 584-586

  Sweeney, Michael O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BRADYCARDIA; COMPARATIVE STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; EDITORIAL; HEART DEATH; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CARDIOMYOPATHIES; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL ISCHEMIA; STROKE VOLUME;

EID: 0038307153     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03129.x     Document Type: Editorial

References (32)

1. Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E, for the AVID Investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmia drugs among patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999;34:1090-1095.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B, for the CIDS Investigators: Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Moonseong H, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1993-1940.
4. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M, on behalf of the CIDS Investigators: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillators Study. Circulation 2000;101:1660-1664.
5. Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ, for the Multicenter Automatic Defibrillator Implantation Trial Research Group: Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary artery disease. Am J Cardiol 2001;88:516-520.
6. Moss AJ: Implantable cardioverter defibrillator therapy: The sickest patients benefit the most. Circulation 2000;101:1638-1640.
7. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
8. Uretsky B, Sheahan G: Primary prevention of sudden cardiac death in heart failure: Will the result be shocking? J Am Coll Cardiol 1997;30:1589-1597.
9. Luu M, Stevenson WG, Saxon LA, Stevenson LW: Diverse mechanisms of unexpected cardiac arrest in heart failure. Circulation 1989;80:1675-1680.
10. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG: Sudden death in patients with implantable cardioverter defibrillators: Importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-1328.
11. DEFIBRILAT Study Group: Actuarial risk of sudden death while awaiting cardiac transplantation among patients with atherosclerotic heart disease. Am J Cardiol 1991;68:545-546.
12. Jeevanadam V, Bielefeld MR, Auteri JS, Sanchez JA, Schenkel FA, Michler RE, Smith CR, Livelli F, Bigger JT, Rose ER, Spotnitz HM: The implantable defibrillator: An electronic bridge to cardiac transplantation. Circulation 1992;86(Suppl II):276-279.
13. Klein H, Troster J, Haverich A: AICD as a bridge to transplant. Rev Eur Technol Biomed 1990;12:110A.
14. Bolling SF, Deeb GM, Morady F, Kadish A, Stirling MC, deBuitlier M, Kirsh M: Automatic internal cardioverter defibrillator: A bridge to heart transplantation. J Heart Lung Transplant 1991;10:562-566.
15. Sander SE, Wiselthaler G, Zuckerman A, Taghavi S, Schmidinger H, Pacher R, Ploner M, Laufer G, Wolner G, Grimm M: Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001;104(12 Suppl 1):171176.
16. Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW: Influence of the implantable cardioverter-defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995;92:3273-3281.
17. Ermis C, Zadeii G, Zhu AX, Fabian W, Collins J, Lurie KG, Sakaguchi S, Benditt DG: Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: Role of beta-blocker or amiodarone treatment. J Cardiovasc Electrophysiol 2003;14:578-583.
18. The Antiarrhythmics Versus Implantable Defibrillator (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
19. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
20. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death among patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
21. Poll DS, Marchlinski FE, Buxton AE, Josephson ME: Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992-997.
22. Kadish A, Schnaltz S, Calkins H, Morady F: Management of nonsustained ventricular tachycardia guided by electrophysiologic testing. Pacing Clin Electrophysiol 1993;16:1037-1050.
23. Lindsay BD, Osborn JL, Schechtman KB, Kenzora JL, Ambos HD, Caine ME: Prospective detection of vulnerability to sustained ventricular tachycardia among patients awaiting cardiac transplantation. Am J Cardiol 1992;69:619-624.
24. Meinertz T, Treese N, Kasper W, Geibel A, Hofmann T, Zehender M, Bohn D, Pop T, Hust H: Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by electrical stimulation. Am J Cardiol 1985;56:337-341.
25. Stamato NJ, O'Connell JB, Murdock DK, Moran JF, Loeb HS, Scanlon PJ: The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation. Am Heart J 1986;112:505-508.
26. Das S, Morady F, DiCarlo L, Baerman J, Krol R, De Buitleir M, Crevey B: Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 1986;59:998-1000.
27. Knight BP, Strickberger SA, Daoud E, Goyal R, Souza J, Sivin A, Morady F: Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999;33:1970-1974.
28. Stevenson WG, Stevenson LW, Weiss J, Tillisch JH: Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J 1988;116:1447-1554.
29. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber R, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL: ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161.
30. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH, for the CAT Investigators: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-1458.
31. SoRelle R. Cardiovascular news. AMIOVIRT. Circulation 2000;102: E9050-E9051.
32. Evans RW, Manninen DL, Dong FB: The National Heart Transplantation Study: Final Report. Seattle, Washington: Battelle Human Affairs Research Centers, 1991.